Clinical Trial, Phase III
"Clinical Trial, Phase III" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Work that is a report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques after phase II trials. A large enough group of patients is studied and closely monitored by physicians for adverse response to long-term exposure, over a period of about three years in either the United States or a foreign country.
This graph shows the total number of publications written about "Clinical Trial, Phase III" by people in Harvard Catalyst Profiles by year, and whether "Clinical Trial, Phase III" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.